Introduction
Systemic lupus erythematosus (SLE) is an autoimmune disease, frequently associated with cardiovascular involvement, such as valvular abnormalities, pericarditis, endocarditis, myocarditis, coronary and pulmonary vessel disease. [1] [2] [3] Mitral valve lesions occur in more than one-third of the patients, mostly leading to mitral regurgitation and rarely to mitral stenosis (MS). [4] [5] [6] Here, we present a case of a 30-year-old women with SLE symptoms and mitral regurgitation eventually leading to MS.
Learning points
• Mitral stenosis in young patients is often due to rheumatic fever.
• Systemic lupus erythematosus (SLE) leads infrequently to mitral valve stenosis. A good clinical evaluation and echocardiography plays a critical role in the diagnosis and follow-up of mitral valve disease caused by SLE. Figure 1A -C and Supplementary material online, Videos S1 and S2).
Subsequent exercise echocardiography revealed an elevation in systolic pulmonary pressures from 39 to 53 mmHg without increased dyspnoea. Mitral valve (MV) gradients went from a peak and mean of 9/4 mmHg to peak and mean of 22/13 mmHg with a calculated mitral valve area (MVA) of 2.0 cm 2 . Three-dimensional echocardiography confirmed the severity of the stenotic orifice with a MVA of 3.0 cm 2 (see Supplementary material online, Video S1).
Immunosuppressive therapy, with cyclophosphamide 500 mg intravenous every 2 weeks and methylprednisolone 64 mg daily for 1 week and afterwards a subsequent progressively decreasing dose, was started. Cyclophosphamide had to be interrupted after two cycles due to recurrent infections. Methylprednisolone 4 mg once a day (q.d.) was continued with clinical improvement (NYHA Class I) and normalization of systolic pulmonary pressure (24 mmHg) after 6 months. After 1 year azathioprine 100 mg q.d. was added to the treatment.
The patient was loss to follow-up during a period of 8 years until she presented with complaints of fatigue and progressive exertional dyspnoea NYHA Class III with a grade five systolic murmur and a facial butterfly rash upon clinical examination. Anti-nuclear antibody increased up to 1:1520 with anti-double stranded DNA (antidsDNA) 1:20 (normal range 1:10 is a negative test). Furthermore, NT-pro-BNP was significantly elevated (10 066 , a normal pericardium and moderate systolic PHT of 40 mmHg at rest. On apical four-chamber view (see Supplementary material online, Video S4) a ball-like density due to the nodular thickening of the anterior leaflet is appreciated.
A subsequent exercise echocardiography permitted us to confirm the severity of the disease since gradients are also flow dependent. One year later, the clinical condition of the patient was significantly improved with a good exercise capacity and stable SLE under methylprednisolone 4 mg q.d, mycophenolate 500 mg three times a day, and hydroxychloroquine 200 mg b.i.d.
Discussion
Systemic lupus erythematosus is more prevalent in women. 1 It is an autoimmune disease that can lead to multiorgan inflammatory damage through the formation and deposition of autoantibodies and immune complexes.
1,2
Cardiac involvement with pericardial and endocardial inflammation is frequently observed. 3 In LS endocarditis, the mitral valve is most often affected, with mitral regurgitation occurring more frequently (25-28%) than MS (2.6-5.8%). [4] [5] [6] [7] [8] [9] Mild inflammatory changes and fibrin-platelet thrombi adhered to the injured valve can lead to valve fibrosis, oedema, and diffuse thickening with valve degeneration as a consequence. 7 Fibrin deposits, neovascularization, hyalinosis, calcinosis, and a variable extent of inflammatory cell infiltration, especially mononuclear cells, can be found. 7 These characteristics were also present in our case. These histological findings are however not specific as they are also seen in rheumatic heart disease. 7 On the other hand, typical Aschoff bodies of rheumatic heart disease (due to rheumatic fever in the past) were not found. 8 Mitral stenosis in young patients is predominantly caused by rheumatic fever in endemic regions. 6, 10 Differential diagnosis of MS in young patients in developed countries includes extensive congenital mitral annular calcification, systemic diseases (SLE, Fabry disease, rheumatoid arthritis) and prior exposure to chest radiation. 6, 9 The diagnosis of MS is based on echocardiography in which restrictive valvular motion is combined with reduced opening of the valve. 10 Evaluation of MS is often difficult and several echocardiographic parameters need to be taken into account such as MVA planimetry, MVA continuity equation calculation (using transmitral diastolic pressure gradient and stroke volume), pulmonary pressures, MVA, proximal isovelocity surface area method (PISA) for the resultant mitral regurgitation. 11 Three dimensional and biplane guided planimetry allow increased accuracy of the mitral valve area measurement.
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In patients with systemic disease such as SLE, fatigue and dyspnoea are frequently present but a direct link to the severity of valvular heart disease is difficult to establish. In addition to a careful clinical evaluation (heart murmur, lung auscultation, jugular venous distention, and the presence of oedema), NT-pro BNP, ANA, antidsDNA, complement C3 and C4, anti-Ro, anti-Sm and a comprehensive two-and three-dimensional echocardiography may be able to provide valuable additional information. 2, 6, 12 Exercise echocardiography has the potential to evaluate the dynamic course of mitral regurgitation and stenosis and its effect on pulmonary pressures and symptoms. 2, 4 In our case, this was helpful in the decision leading to valve replacement. According to recent ESC guidelines, cardiac MRI is of additional value, more specifically for quantification of valvular regurgitation. In addition, myocardial and pericardial catheterization might bring added value in systemic diseases. Also coronary computed tomography can exclude coronary artery disease in this patient population with intermediate cardiovascular risk whenever exercise test is inconclusive or not possible. 6 One might speculate that the case we present would not have deteriorated towards severe MS as she had been more compliant to immune suppressive treatment. However, no studies showed clear relation between flares of SLE and the presence and severity of LS endocarditis. Moreover, even though corticoids reduce valvular inflammation and facilitate healing of valvular vegetations, they are known to also increase fibrosis and valvular deformation. 13 The outcome seems good in most SLE patients who have undergone valvular surgery, but association of antiphospholipid antibody syndrome with SLE has negative impact on the outcome.
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Conclusion
Severe MS is an infrequent complication of SLE (LS endocarditis). Comprehensive two-and three-dimensional echocardiography at rest and during stress are important for correct diagnosis and treatment of LS endocarditis.
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